Search results
Showing 1751 to 1800 of 2065 results for work
IMI and H2020 Grant funded projects with NICE
NICE public committee meetings supports our commitment to having processes in place that are rigorous, open, and transparent.
Technology appraisal guidance makes recommendations on the use of new and existing medicines and other treatments within the NHS.
Providing an advisory service for international health organisations, ministries and government agencies whose task is to improve evidence-based decision making in health and social care
"name":"NICE International"}}]} Transforming global healthcare: success stories We work with health organisations in the UK and around...
Our stakeholders are involved in the development of NICE guidance and quality standards to ensure that the recommendations are relevant, practical, and meet the needs of those affected by the health or social care issues addressed.
Find out more about the types of organisations that can register to be a stakeholder at NICE.
Information and benefits about shared decision making. Includes links to patient decision aids.
a stakeholder People and communities - putting you at the heart of our work Help develop quality standards Help us improve Help...
Guide for lay members who we've invited to sit on one of NICE's committees, panels, or groups.
NICE works with partners including Public Health England, NHS England and NHS Improvement to assess services and support innovation and best practice.
The guidance development timeline
People coming off obesity medication or finishing a weight management programme should be offered support to help keep the weight off and stay healthy long-term, according to our updated quality standard.
Patients to receive medicines 3 to 6 months faster under 10-Year Health Plan
NICE and the Medicines and Healthcare products Regulatory Agency (MHRA) have described how the 10-Year Health Plan will lead to faster medicines access for patients in the NHS in England.
How providers and commissioners can use quality standards to improve the quality of care
Science policy projects with NICE.
NICE Advice - a fee-based advisory service for pharmaceutical and healthtech companies seeking to enter the NHS market,
We're at the forefront of bringing better care to people. We help practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
specific websites only. 3. The NICE website provides information about NICE's work, including its recommendations on the use of health...
NICE Advice works closely with our system partners and industry to drive innovation into the hands of health and care professionals, to enable best practice.
Evidence standards framework (ESF) for digital health technologies
NICE standards for innovators of digital health technologies and NHS commissioners
Final decision on cerliponase alfa for Batten disease treatment confirmed
In final draft guidance published today we've confirmed that we’re unable to recommend cerliponase alfa (also called Brineura and made by BioMarin) for routine NHS use in treating neuronal ceroid lipofuscinosis type 2 (CLN2), a rare and life-limiting form of Batten disease.
Stakeholder registration: guidelines, quality standards and indicators
How to register as a stakeholder to help us develop guidelines, quality standards and indicators.
Embed NICE content in your digital products and services with our syndication API.
audit Social care Using NICE guidance in social work: scenarios Using NICE guidance in social work: scenarios for principle...
NICE committees are made up of people like you. They include experts in health and social care, people who use health and care services and carers. Your involvement is highly valued. We are guided by your knowledge and experience.
Learn about NICE's proportionate approach to technology appraisals, which aims to streamline the evaluation process for new health technologies, ensuring timely access to innovative treatments while maintaining rigorous standards.
The time and proportion of pay used by trade union representatives to carry out their union role.
Hundreds with rare inherited eye disease to benefit after NICE recommends treatment
NICE recommends idebenone for Leber's hereditary optic neuropathy following clinical evidence of vision improvement.
Agenda and papers of the NICE public board meeting on 17 May 2023
Agenda and papers of the NICE public board meeting on 22 July
Charging procedure for NICE technology appraisal and highly specialised technologies evaluations
After four years of transformational leadership, NICE CEO Dr Sam Roberts will step down at the end of the year to support her children through a difficult time.
NICE's equality, diversity, and inclusion roadmap and annual action plan - committed to creating a forward-looking, positive work culture where everyone can thrive.
The principles that guide the development of NICE guidance and standards.
People have the right to be able to make informed decisions about their care. Our guidance should be taken into account when making decisions with them.
Read NICE's statement on modern slavery and human trafficking.
We're working with colleagues to ensure that virtual wards are used in a way that maximises the value for patients and the NHS.
Ask an expert from NICE International, part of the UK's National Institute for Health and Care Excellence, to speak at a healthcare event in your country
Get expert advice and support from NICE International, part of the UK's National Institute for Health and Care Excellence, for a project in your country
The Office for Digital Health strives to accelerate NICE's efforts to deliver innovation to the health and care system.
audit Social care Using NICE guidance in social work: scenarios Using NICE guidance in social work: scenarios for principle...
Tools for building or evaluating a medtech evidence base with NICE
Our science policy and research programme team produces high-quality, impactful research.
Our indicators measure outcomes that reflect the quality of care or processes linked by evidence to improved outcomes.
Institute for Health and Care Excellence. We also officially took on the work of bringing evidence-based guidance and standards to the...
Some people with cystic fibrosis are set to benefit from a new once-daily triple therapy treatment, following NICE's recommendation of Alyftrek in final draft guidance published today.
How NICE International is supporting evidence-based decision-making through the Regulatory Partnership for Growth Fund
Help make a difference on behalf of the people most affected by our recommendations on our voluntary and community sector forum.
NICE's technology appraisal guidance makes recommendations on the use of new and existing medicines and other treatments within the NHS.